Mouse Experiment Suggests We Might Sleep Off Toxic Memories
One area of brain science that has drawn intense interest in recent years is the study of what psychologists call reconsolidation—a ponderous technical term that, once translated, means giving yourself a second chance.
Cost to Develop New Pharmaceutical Drug Now Exceeds $2.5B
A benchmark report estimates that the cost of bringing a drug to market has more than doubled in the past 10 years
Pay per Puff? E-Cigarette Boom Sparks Race for New Patents
By Martinne Geller and Ben Hirschler LONDON (Reuters) - Electronic cigarette makers are racing to design and buy variations of a technology that has lit a billion-dollar boom, created a new vocabulary, and prompted a backlash from health officials worried about the impact of the new smokeless devices.
Deceptive Practices in Drugs Research Could Become Harder
The proposed crack-down would close loopholes that allow researchers to hide negative findings and harmful side effects
Care of the Wounded, 1914
Reported in Scientific American, This Week in World War I: November 21, 1914 From the Scientific American Supplement issue of November 21, 1914, we note, "The first object of an army in war is to disperse or destroy the enemy, but a correlative duty is the care of its own men when wounded or otherwise [...]
Battle of the `Staches Raises Money for Men's Health
People who donate money or fundraise for a cause are often silent heroes. However, unlike many fundraising efforts, it's readily apparent who's participating in one that's currently taking the nation by its facial hair.
A Day in the Life of an Ebola Worker
Denial, violence and fear make it difficult to stamp out Ebola in west Africa
In a Lather Over Triclosan? Thumbs Down to Fear Mongering Soap Operas
Another day, another fuss about an animal study. This time, it’s a cancer scare around a common antibacterial in soaps: triclosan. “The dirty side of soap,” says the headline on the university’s press release.
Controversial Cholesterol Drug Reduces Risk of Heart Disease
The ability of ezetimibe to combat heart disease previously was in dispute
Improved Ebola Situation in Liberia May Complicate Vaccine Trials
As fewer people get sick, the trials may need to include more participants than planned to deliver usable results
South Africa to Spend $2.2 billion on HIV Drugs in Next 2 Years
South Africa plans to spend $2.2 billion over two years to buy HIV/AIDS drugs for public hospitals, a government minister said on Monday, as a study shows the prevalence of the virus is rising
Learning About Your Family's Elevated Alzheimer's Risk—As Early As Age Eight
A Colombian university is providing regular workshops on brain basics and genetics to grade schoolers from families who face a high risk of developing Alzheimer's in the prime of life from a rare genetic mutation.